Dataset Information


The miRNA expression signature of human MALT lymphoma

ABSTRACT: To identify key tumour supressor miRNAs involed in MALT lymphoma pathogenesis Gastric mucosa-associated lymphoid tissue lymphoma develops in the chronically inflamed mucosa of Helicobacter pylori-infected patients. MicroRNA expression profiling of human MALT lymphoma revealed a 10-fold down-regulation of miR-203, which resulted from promoter hypermethylation and coincided with the dysregulation of the miR-203 target ABL1. Demethylating treatment of lymphoma B-cells led to an increase in miR-203 expression and concomitant ABL1 down-regulation. The lentiviral delivery of miR-203, as well as treatment with various ABL inhibitors, prevented primary MALT lymphoma cell proliferation in vitro. Finally, the treatment of tumor-bearing mice with imatinib induced MALT lymphoma regression in vivo. Our results show that MALT lymphomagenesis is epigenetically induced by miR-203 promoter methylation and identify ABL1 as a novel target for the treatment of this malignancy. Overall design: 5 human fresh frozen MALT lymphoma samples were analysed and 4 human tonsil tissue samples were used as the non-tumour control

INSTRUMENT(S): Agilent-021827 Unrestricted Human 15.7K v3.0 miRNA Microarray

ORGANISM(S): Homo sapiens  

SUBMITTER: Vanessa Jane Craig  

PROVIDER: GSE23877 | GEO | 2010-08-31



Similar Datasets

2010-08-31 | E-GEOD-23877 | ArrayExpress
2012-07-09 | E-GEOD-25638 | ArrayExpress
2012-07-09 | E-GEOD-25637 | ArrayExpress
| GSE25550 | GEO
2008-10-30 | GSE13314 | GEO
2012-07-09 | E-GEOD-25636 | ArrayExpress
| GSE48047 | GEO
| GSE24485 | GEO
2010-10-07 | GSE16024 | GEO
2012-07-09 | E-GEOD-25639 | ArrayExpress